We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nuclear Medicine Approach Shows Promise for Treating Cancerous Tumors

News   Jun 26, 2018 | Original story from Society of Nuclear Medicine and Molecular Imaging (SNMMI)

 
Nuclear Medicine Approach Shows Promise for Treating Cancerous Tumors

225Ac-proteus-DOTA hapten can be targeted in vivo to GPA33-expressing human colorectal cancer xenografts using anti-GPA33-DOTA-PRIT, with minimal radioactive uptake in critical radiosensitive tissues such as blood and kidney. In addition, indium-111 can be used in place of 225Ac as a convenient imaging surrogate (biomarker) of 225Ac in vivo biodistribution and dosimetry. Credit: SM Cheal et al., Memorial Sloan Kettering Cancer Center, New York, NY.

 
 
 

RELATED ARTICLES

A Third "Short Sleep" Gene Has Been Discovered – And It Prevents Memory Deficits

News

In a new study, scientists have discovered a third "short sleep" gene. It is the first gene to be identified that prevents the memory deficits typically associated with sleep deprivation.

READ MORE

AI Could Warn About Drug Interaction Side Effects

News

Researchers have designed an algorithm that analyzes data on drug-drug interactions listed in reports — compiled by the Food and Drug Administration and other organizations — for use in a possible alert system that would let patients know when a drug combination could prompt dangerous side effects.

READ MORE

A Mouse Model of the Human Gene Involved in Alzheimer’s Disease Is Created

News

Scientists have developed a line of mice in which the mouse version of the Alzheimer's-associated MAPT gene has been fully replaced by the human version of the gene.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE